• Nem Talált Eredményt

18 eredmény a kulcsszóra: 'liver disease'

4.4.2 Academic support and students’ academic performance

The study found that factors of school learning environment such as infrastructure, facilities, teacher quality, teaching approaches, academic support,

Protected

N/A

158
0
0
2022
Janakieff, Rumen: Elméleti statisztika, statisztikai módszerek és matematika

Ha az S azon cikkek várható mennyisége, amely az utánpótlási idő alatt esetleg meghaladja az x utánrendelési szintet, akkor az egy ciklusra eső átlagos

Protected

N/A

2
0
0
2022
nonalcoholic fatty liver disease

Considering the powerful association between NAFLD, insulin resistance (IR) and obesity, as well as the key role of ghrelin in these metabolic disorders, we hypothesized that

Protected

N/A

11
0
0
2022
Liver transplantation

Liver transplantation is the only treatment in end-stage liver disease and acute liver failure which can provide a long-term survival.. The average 5-year survival rate after

Protected

N/A

4
0
0
2022
The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia

Keywords: Primary sclerosing cholangitis, Liver cirrhosis, Cholangiocarcinoma, Immunoglobulin A, Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis,

Protected

N/A

14
0
0
2022
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?

Key words: Non-alcoholic fatty liver disease; Non- alcoholic steatohepatitis; Liver cirrhosis; Hepatocellular cancer; Dysfunctional adipose tissue; Type 2 diabetes

Protected

N/A

19
0
0
2022
adult-onset Still’s disease

We report a 41-year-old male with undiagnosed adult Still’s disease who underwent liver transplantation due to acute fulminate liver failure.. He died 6 months after the

Protected

N/A

5
0
0
2022
Ŕperiodicapolytechnica RemittancesandtheirimpactonEconomicGrowth

The major po- tential channels of the positive e ff ects of remittance inflows on the growth and development prospects of developing economies include how these remittances impact

Protected

N/A

17
0
0
2022
TÁMOP-4.1.2-08/1/A-2009-0034 projekt Regionális turisztikai menedzsment /BSc/

 Teljes körű rendezvényszervező cégekkel: konferenciaszervező irodákkal, amennyiben az iroda alvállalkozásként működik közre más konferenciák szervezésében

Protected

N/A

19
0
0
2022
1Introduction ExistenceandglobalattractivityofperiodicsolutionforimpulsivestochasticVolterra-Levinequations

Our results imply that under the appropriate linear periodic impulsive perturbations, the impulsive stochastic Volterra-Levin equations preserve the original periodic property of

Protected

N/A

12
0
0
2022
Speciális májműtét (Associating Liver Partition and Portal vein ligation for Staged hepatectomy, ALPPS) morbiditásának csökkentése átértékelt betegkiválasztási elvek és műtéttechnikai módosítás révén

INR = (international normalized ratio) nemzetközi normali- zált arány; MELD = (model for end-stage liver disease) a vég- stádiumú májbetegség modellje; PHLF = (posthepatectomy

Protected

N/A

10
0
0
2022
HYERS-ULAM STABILITY OF THE GENERALIZED QUADRATIC FUNCTIONAL EQUATION IN AMENABLE SEMIGROUP

Key words: Hyers-Ulam stability, Quadratic functional equation, Amenable semigroup, Morphism of semigroup.... Hyers-Ulam Stability Bouikhalene Belaid,

Protected

N/A

36
0
0
2022
PETRAPÁJER,IMREFEHÉRVÁRI InvestigationofRenalFunctioninLiverTransplantPatients:MDRDorCockroft–Gault?

CKD = chronic kidney disease; CV = cardiovascular; GFR = glomerular filtration rate; eGFR = estimated glomerular filtration rate; MELD = Model for Endstage Liver Disease; NSAID

Protected

N/A

9
0
0
2022
Digestive and Liver Disease ARTICLE IN PRESS

The aim of the present study was to evaluate the clinical ef- ficacy, drug sustainability, frequency of dose intensification, and results from therapeutic drug monitoring in

Protected

N/A

7
0
0
2022
Journal of Digestive Diseases and Hepatology

Keywords: Metformin; Non-alcoholic fatty pancreas and liver disease; Pericardial adipose tissue; Type 2 diabetes

Protected

N/A

8
0
0
2022
DSP Selection Guide 2002 Edition

Analog Devices is the world's fastest-growing DSP supplier. Our portfolio includes mixed-signal DSPs, general-purpose DSPs, such as the SHARC ® , TigerSHARC ® , Blackfin  ,

Protected

N/A

62
0
0
2022
Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

Fasting serum DPP-4 enzymatic activities in patients with type 2 diabetes without clinically diagnosed liver disease (2TD group); in NAFLD patients with normal and abnormal

Protected

N/A

7
0
0
2022
Születésünk után

Bár korábban nem tudtam még, mit keresek s miért élek, csak vártam, hogy jelezzen az idő, s ideám bezártam, hogy megtört képzetem életterében testet ölts végre, hogy

Protected

N/A

89
0
0
2022

Töltsön fel további dokumentumokat, és töltse le azonnal az anyagtanulmányokat!